Cytek Biosciences Inc (CTKB) — Free Cash Flow Generation Index
Cytek Biosciences Inc (CTKB) has a Free Cash Flow Generation Index of -13.60x as of June 2025. Free cash flow of $-1.47 Million represents -14% of operating cash flow ($108.00K). Read Cytek Biosciences Inc total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Cytek Biosciences Inc Free Cash Flow Generation Index (2020–2024)
Historical FCF Generation Index trend for Cytek Biosciences Inc across 4 annual periods. Explore Cytek Biosciences Inc (CTKB) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Cytek Biosciences Inc (2020–2024)
Year-by-year Free Cash Flow Generation Index for Cytek Biosciences Inc. For the full company profile including market capitalisation, see CTKB stock market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.86x | $21.85 Million | $25.38 Million | $3.52 Million | ▲ +901.7% |
| 2023 | 0.09x | $454.00K | $5.28 Million | $4.83 Million | ▲ +49.6% |
| 2021 | 0.06x | $266.00K | $4.63 Million | $4.36 Million | ▼ -93.6% |
| 2020 | 0.90x | $13.61 Million | $15.16 Million | $1.55 Million | — |